Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare launches ₹600 crore fundraise via QIP
Blue Jet Healthcare has launched a ₹600 crore qualified institutional placement (QIP), with the issue priced at an indicative ₹506 per share, a 10% discount to Monday's closing price.
India's wellness industry poised for growth amid focus on preventive healthcare, rising income: EBG Group chief
India's wellness market, valued at over $150 billion, is set for growth fueled by rising health consciousness and disposable incomes. EBG Group is launching Carlton Wellness India, an integrated ecosystem blending traditional Indian healing with modern hospitality. This platform will offer diverse wellness experiences, from city centers to retreats, emphasizing preventive care and holistic wellbeing for everyday life.
Suzuki Motor arm Next Bharat Ventures launches ₹2,000 crore second impact fund to back rural entrepreneurs
Next Bharat Venture’s second fund will focus on agriculture, financial inclusion, healthcare, and AI for social good among others.
Metropolis Healthcare climbs as Q1 revenue climbs 16% YoY
Metropolis Healthcare jumped 2.97% to Rs 568.40 after the company's revenue grew around 16% YoY in Q1 FY27, driven by patient volumes along with realization benefits due to product mix change.
Healthcare stock Unihealth Hospitals hits 5% upper circuit; here's why
Unihealth Hospitals shares hit the 5% upper circuit after announcing a 49.81% stake acquisition in Uganda's Victoria Hospital, boosting its ownership to 99.81%. This strategic move supports its international expansion goals and ensures future economic benefits directly benefit its shareholders.
Stocks to Watch today: HDFC Bank, Coal India, Tata Steel, Sobha, BoB, Nykaa
Stocks to watch today: HDFC Bank, Coal India, Tata Steel, Sobha Ltd, Bank of Baroda, Radico Khaitan, Senco Gold, Fortis Healthcare, IndusInd Bank, Dabur, among others, will be in focus today.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Nasdaq futures rise 400 points after chip sell-off, strong truncated week
Mark Newton of Fundstrat wrote that financials, healthcare and industrial stocks closed at record levels last week, more than offsetting the underperformance of chipmakers. He now sees the S&P 500 at 8,000 by mid-August, that is a 7% jump in just over a month.
Is enforcement of banking regulations ownership neutral?
Bank of Baroda settled a $600 million dispute with NMC Healthcare administrators, ending a protracted legal battle. This significant payout, wiping out a quarter of its projected profit, raises serious questions about the bank's governance and disclosure practices. The settlement, reached without admitting fault, highlights a perceived leniency in regulatory oversight for state-owned banks compared to private institutions, prompting calls for more equitable enforcement.
Is enforcement of banking regulations ownership neutral?
Bank of Baroda settled a $600 million dispute with NMC Healthcare administrators, ending a protracted legal battle. This significant payout, wiping out a quarter of its projected profit, raises serious questions about the bank's governance and disclosure practices. The settlement, reached without admitting fault, highlights a perceived leniency in regulatory oversight for state-owned banks compared to private institutions, prompting calls for more equitable enforcement.
Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcare
Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials contained only water, not the active ingredient. The manufacturer, Jackson Laboratories, has had stop-production orders earlier as well. This incident has put focus on critical failures in drug regulation and raises serious concerns about patient safety.
WhiteOak’s Prashant Khemka stays bullish on healthcare, small NBFCs and manufacturing-led growth
WhiteOak Capital Group Founder Prashant Khemka remains positive on healthcare, citing strong opportunities across pharmaceuticals, hospitals and diagnostics due to the sector's diverse listed companies.